甘李药业
(603087)
| 流通市值：372.65亿 | | | 总市值：399.00亿 |
| 流通股本：5.58亿 | | | 总股本：5.97亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,064,233,725.12 | 1,091,493,920.76 | 1,058,837,161.68 | 902,777,760.68 |
| 交易性金融资产 | 1,102,024,616.43 | 1,145,750,178.09 | 1,297,700,883.56 | 1,500,496,835.63 |
| 应收票据及应收账款 | 534,869,170.3 | 511,709,595.45 | 334,339,125.08 | 225,960,734.2 |
| 其中：应收票据 | 5,241,627.7 | 7,134,216.08 | 6,091,659.92 | 12,246,237.38 |
| 应收账款 | 529,627,542.6 | 504,575,379.37 | 328,247,465.16 | 213,714,496.82 |
| 应收款项融资 | 19,767,346 | 927,560 | 5,147,466.99 | 20,758,005.45 |
| 预付款项 | 78,497,686.89 | 61,170,818.23 | 51,527,747.22 | 56,562,468.46 |
| 其他应收款合计 | 4,004,977.13 | 1,640,434.62 | 3,108,901.33 | 1,847,488.41 |
| 存货 | 1,125,094,142.08 | 1,114,813,922.99 | 1,113,062,811.37 | 1,052,906,832.75 |
| 一年内到期的非流动资产 | 7,162,141.25 | 6,471,133.1 | 5,816,625.61 | 5,089,557.41 |
| 其他流动资产 | 32,843,010.07 | 32,191,364.1 | 30,732,217.91 | 24,458,526.06 |
| 流动资产合计 | 4,968,496,815.27 | 3,966,168,927.34 | 3,900,272,940.75 | 3,790,858,209.05 |
| 非流动资产: | | | | |
| 债权投资 | 508,147,397.07 | 504,399,954.91 | 500,693,245.81 | 497,027,269.78 |
| 长期应收款 | 6,318,665.85 | 6,940,413.49 | 7,025,028.27 | 7,669,407.96 |
| 其他非流动金融资产 | 72,190,190.44 | 71,142,310.21 | 46,500,132.7 | 11,713,152.96 |
| 固定资产 | 2,472,416,874.48 | 2,576,062,927.88 | 2,620,823,241.17 | 2,615,687,526.41 |
| 在建工程 | 1,348,296,006.45 | 1,259,965,114.37 | 1,253,137,910.49 | 1,262,027,468.83 |
| 使用权资产 | 3,264,225.79 | 3,627,104.12 | 3,977,149.53 | 4,323,594.06 |
| 无形资产 | 263,726,341.5 | 264,271,627.78 | 266,659,170.69 | 273,059,639.42 |
| 开发支出 | 1,392,805,454.24 | 1,205,216,940.76 | 1,045,134,396.87 | 917,812,401.72 |
| 长期待摊费用 | 5,774,139.35 | 6,216,507.92 | 6,658,839.21 | 7,101,160.03 |
| 递延所得税资产 | 228,780,920.03 | 220,865,325.25 | 213,850,575.46 | 206,935,277.52 |
| 其他非流动资产 | 872,540,656.49 | 1,792,918,355.76 | 2,419,702,187.84 | 2,448,701,284.14 |
| 非流动资产合计 | 7,174,260,871.69 | 7,911,626,582.45 | 8,384,161,878.04 | 8,252,058,182.83 |
| 资产总计 | 12,142,757,686.96 | 11,877,795,509.79 | 12,284,434,818.79 | 12,042,916,391.88 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 126,494,605.62 | 105,408,368.04 | 112,916,647.49 | 129,129,386.84 |
| 应付账款 | 126,494,605.62 | 105,408,368.04 | 112,916,647.49 | 129,129,386.84 |
| 预收款项 | 30,275.24 | 45,412.85 | - | - |
| 合同负债 | 49,109,519.63 | 55,263,802.31 | 54,027,662.66 | 63,254,168.23 |
| 应付职工薪酬 | 168,727,631.84 | 134,334,251.28 | 167,434,441.77 | 150,681,683.52 |
| 应交税费 | 15,859,468.75 | 15,881,267.49 | 11,840,226.55 | 11,191,413.07 |
| 其他应付款合计 | 320,749,555.25 | 407,935,147.45 | 431,848,339.35 | 426,587,948.23 |
| 一年内到期的非流动负债 | 5,793,669.61 | 8,277,330.82 | 8,399,982.16 | 10,056,983.05 |
| 其他流动负债 | 3,692,205.9 | 7,924,910.11 | 6,747,296.88 | 10,230,151.3 |
| 流动负债合计 | 690,456,931.84 | 735,070,490.35 | 793,214,596.86 | 801,131,734.24 |
| 非流动负债: | | | | |
| 租赁负债 | 2,582,321.88 | 2,804,668.8 | 3,056,451.84 | 3,306,003.23 |
| 长期应付款 | 2,646,761.09 | 2,646,761.09 | 2,646,761.09 | 2,973,351.09 |
| 递延收益 | 164,679,201.12 | 166,991,805.64 | 168,829,847.63 | 168,923,889.62 |
| 递延所得税负债 | - | 5,051,071.85 | 4,563,711.77 | 12,110,751.52 |
| 非流动负债合计 | 169,908,284.09 | 177,494,307.38 | 179,096,772.33 | 187,313,995.46 |
| 负债合计 | 860,365,215.93 | 912,564,797.73 | 972,311,369.19 | 988,445,729.7 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 597,304,969 | 601,065,290 | 601,065,290 | 601,065,290 |
| 资本公积 | 3,521,754,334.76 | 3,630,545,205.33 | 3,611,154,661.55 | 3,590,961,537.76 |
| 减:库存股 | 120,692,360 | 335,804,611.36 | 275,644,784.92 | 200,846,739.31 |
| 其他综合收益 | 3,630,190.9 | 4,015,906.54 | 4,375,941.88 | 4,036,955.66 |
| 盈余公积 | 300,532,645 | 300,532,645 | 300,532,645 | 300,532,645 |
| 未分配利润 | 6,979,862,691.37 | 6,764,876,276.55 | 7,070,639,696.09 | 6,758,720,973.07 |
| 归属于母公司股东权益合计 | 11,282,392,471.03 | 10,965,230,712.06 | 11,312,123,449.6 | 11,054,470,662.18 |
| 股东权益合计 | 11,282,392,471.03 | 10,965,230,712.06 | 11,312,123,449.6 | 11,054,470,662.18 |
| 负债和股东权益合计 | 12,142,757,686.96 | 11,877,795,509.79 | 12,284,434,818.79 | 12,042,916,391.88 |
| 公告日期 | 2025-10-31 | 2025-08-08 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |